Canopy Growth (CGC) Update
Canopy Growth Activates Our Anticipated Fibonacci Retracement Zone
On March 17, 2026, we published our Elliott Wave analysis for Canopy
1 min read
Health & Biotech
From pharmaceutical giants and health insurers to cutting-edge biotech and gene-editing pioneers — this sector tracks the companies advancing human health and medicine.
22 posts
Canopy Growth (CGC) EW-Analysis
Canopy Growth — Has the Historical Bottom Been Reached?
Since its IPO, Canopy Growth experienced a massive bull run, reaching an
2 min read
Hims & Hers Health Update
We can now successfully deactivate our anticipated Fibonacci retracement zone.
This chart shows our analysis from March 3rd, 2026, where
2 min read
Tilray brands (TLRY) EW-Analysis
Since its IPO in July 2018, Tilray Brands reached an all-time high of $3,000 before entering a prolonged corrective
2 min read
Merck KGaA (MRK) EW-Analysis
Where is the end of this correction?
Since 2002, Merck has shown a structurally clean price action. The formation of
2 min read
Moderna (MRNA) EW-Analysis
This stock is forming a major bull market.
The Moderna stock is a very interesting asset. Since its IPO in
2 min read